Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Blog

Here's Why UMB Financial (UMBF) is a Strong Value Stock
Here's Why UMB Financial (UMBF) is a Strong Value Stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both.

The popular research

Are Investors Undervaluing Mercedes-Benz Group AG (MBGYY) Right Now?
Are Investors Undervaluing Mercedes-Benz Group AG (MBGYY) Right Now?

The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always

Is Dutch Bros Winning the Coffee Wars With Traffic, Not Pricing?
Is Dutch Bros Winning the Coffee Wars With Traffic, Not Pricing?

Dutch Bros Inc. BROS is increasingly standing out in the crowded coffee landscape by leaning on traffic growth rather than aggressive pricing. The company’s third-quarter 2025 results underscore a

Buy 5 Stocks With High ROE as U.S. Economy Appears on Firm Footing
Buy 5 Stocks With High ROE as U.S. Economy Appears on Firm Footing

The broader equity markets continued to trade in record territory after a minor blip mid-week. The uptrend was buoyed by relatively modest job market conditions, with the December jobs report

With ROIC at 19-Year Highs, Is CCL Entering a New Profitability Cycle?
With ROIC at 19-Year Highs, Is CCL Entering a New Profitability Cycle?

Carnival Corporation & plc’s CCL latest earnings call highlights a potential inflection point in its long-term profitability. Management reported return on invested capital (“ROIC”) above 13% in

Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround
Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a Turnaround

A downtrend has been apparent in Aquestive Therapeutics (AQST) lately with too much selling pressure. The stock has declined 37% over the past four weeks. However, given the fact that it is now in

Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)

AngioDynamics (ANGO) has been on a downward spiral lately with significant selling pressure. After declining 25% over the past four weeks, the stock looks well positioned for a trend reversal as it

Can Estee Lauder's Fragrance Strength Drive Top-Line Growth?
Can Estee Lauder's Fragrance Strength Drive Top-Line Growth?

The Estee Lauder Companies Inc. (EL) has pointed to fragrance as a meaningful driver of organic sales growth. In the first quarter of fiscal 2026, fragrance was the company’s strongest-performing

SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock?
SMCI Plunges 45% in 3 Months: Time to Buy, Sell or Hold the Stock?

Super Micro Computer SMCI shares have plunged 44.9% in the past three months, underperforming the Zacks Computer- Storage Devices industry and the Zacks Computer and Technology sector’s appreciation

Exelixis Posts Preliminary '25 Results, Issues '26 Outlook
Exelixis Posts Preliminary '25 Results, Issues '26 Outlook

Exelixis, Inc. EXEL reported preliminary, unaudited financial results for fiscal year 2025, issued financial guidance for fiscal 2026, and provided a business update.

However, the stock is down in

INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced
INSM Stock Jumps on 2025 Preliminary Sales, 2026 Goals Announced

Shares of Insmed INSM gained more than 3% on Friday after the company reported preliminary sales numbers for full-year 2025. It also outlined some expected milestones related to its commercial

Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Wall Street Analysts See Coupang (CPNG) as a Buy: Should You Invest?
Wall Street Analysts See Coupang (CPNG) as a Buy: Should You Invest?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?
Wall Street Bulls Look Optimistic About Merck (MRK): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?
CRISPR Therapeutics (CRSP) Is Considered a Good Investment by Brokers: Is That True?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Wall Street Analysts See Toyota Motor (TM) as a Buy: Should You Invest?
Wall Street Analysts See Toyota Motor (TM) as a Buy: Should You Invest?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It?
Wall Street Analysts Think CleanSpark (CLSK) Is a Good Investment: Is It?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views?
Should You Invest in Gray Media (GTN) Based on Bullish Wall Street Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Is It Worth Investing in SkyWater Technology (SKYT) Based on Wall Street's Bullish Views?
Is It Worth Investing in SkyWater Technology (SKYT) Based on Wall Street's Bullish Views?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Why This 1 Medical Stock Could Be a Great Addition to Your PortfolioPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png
Why This 1 Medical Stock Could Be a Great Addition to Your Portfolio

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Brokers Suggest Investing in APTIV HLDS LTD (APTV): Read This Before Placing a Bet
Brokers Suggest Investing in APTIV HLDS LTD (APTV): Read This Before Placing a Bet

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

Wall Street Bulls Look Optimistic About Clear Secure (YOU): Should You Buy?
Wall Street Bulls Look Optimistic About Clear Secure (YOU): Should You Buy?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch
Earnings Growth & Price Strength Make CBRE Group (CBRE) a Stock to Watch

Here at Zacks, we offer our members many different opportunities to take full advantage of the stock market, as well as how to invest in ways that lead to long-term success.

The Zacks Premium

Amphenol (APH) Crossed Above the 50-Day Moving Average: What That Means for Investors
Amphenol (APH) Crossed Above the 50-Day Moving Average: What That Means for Investors

Amphenol (APH) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, APH broke out above the 50-day moving average, suggesting a

Altria's Discount Strategy: Is Basic Brand a Smart Move for It?
Altria's Discount Strategy: Is Basic Brand a Smart Move for It?

Altria Group, Inc. (MO) is leaning more on its discount cigarette offerings as rising costs make adult smokers more price-conscious. In the third quarter of 2025, the broader U.S. cigarette industry